about
Antidepressants for people with epilepsy and depressionAntidepressants for people with epilepsy and depressionAdvances of Molecular Imaging in EpilepsyLow-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndromeThe role of dopaminergic and serotonergic systems in neurodevelopmental disorders: a focus on epilepsy and seizure susceptibilityBehavioral, Ventilatory and Thermoregulatory Responses to Hypercapnia and Hypoxia in the Wistar Audiogenic Rat (WAR) StrainA single amino acid mutation in SNAP-25 induces anxiety-related behavior in mouseMonoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target DrugsCentral serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?Activity-dependent expression of Lmx1b regulates specification of serotonergic neurons modulating swimming behaviorTranscriptomic Profiling of Medial Temporal Lobe Epilepsy.The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsySeizure Reduction with Fluoxetine in Dravet Syndrome.5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders.Serotonin-mediated modulation of Na+/K+ pump current in rat hippocampal CA1 pyramidal neurons.Elevated serotonergic signaling amplifies synaptic noise and facilitates the emergence of epileptiform network oscillations.Human Ecstasy use is associated with increased cortical excitability: an fMRI study.The anticonvulsant effects of SR 57227 on pentylenetetrazole-induced seizure in miceCell signaling underlying epileptic behavior.Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsyIntra- and Interhemispheric Propagation of Electrophysiological Synchronous Activity and Its Modulation by Serotonin in the Cingulate Cortex of Juvenile MiceRole for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures.Seizure developed after palonosetron intravenous injection during recovery from general anesthesia -A case report-.Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?Abnormal cell-intrinsic and network excitability in the neocortex of serotonin-deficient Pet-1 knockout mice.The role of dopamine signaling in epileptogenesis.Pathogenesis of epilepsy: challenges in animal modelsSerotonin Regulates the Firing of Principal Cells of the Subiculum by Inhibiting a T-type Ca2+ Current.Escitalopram causes fewer seizures in human overdose than citalopram.The serotonin axis: Shared mechanisms in seizures, depression, and SUDEP.Psychiatric symptomatologies and disorders related to epilepsy and antiepileptic medications.Dystrophic serotonin axons in postmortem brains from young autism patients.α-methyl-L-tryptophan: mechanisms for tracer localization of epileptogenic brain regions.Central mechanisms of cranial nerve stimulation for epilepsyThe role of different serotonin receptor subtypes in seizure susceptibility.Increasing awareness of sudden unexpected death in epilepsy.Mechanisms of sudden unexpected death in epilepsy: the pathway to prevention.The dilemma of treatments for epileptic patients with depression.Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.
P2860
Q24187468-5D27C4F5-02BC-4E44-8FDB-53D46EE091D3Q24201510-5A0B247F-BC31-4529-834A-6DE21549F96FQ26750477-5E6F83FB-D7C5-493B-AF10-4F75AC667D41Q26776222-1F9F1C9F-8DEC-401A-83E3-CD0434AACC21Q26801864-3F4EA78C-D870-4C65-B42D-02F6E4A082B4Q27312500-8C0252BA-3D88-4775-A4DD-E956F749A644Q27319110-12A7EC77-E430-4D0C-9329-FD465E66A93DQ28074736-DE7B0239-5CE4-40BE-970A-943DB625C77CQ28080944-D49E7053-8CEA-4B02-8D9C-2476EF68A62FQ30495806-3F8DDAB8-AA6E-47FD-8A52-E7ECC23978F6Q30537365-6F518B18-DDCF-4822-87EC-E7C7583456A5Q30540038-9BE0FC60-E40E-4162-8379-FC897231EE0AQ33773087-509D3AAC-81CF-4522-A871-52C456787E6FQ34093279-8DD0243A-8CAA-419B-95FE-6C485346E62FQ34132556-1479C568-1621-4488-9871-D9EE66CE2E96Q34519135-01A1DF74-94E4-4CC5-8A05-DB9978299662Q34820201-A3B75BB4-B213-4637-B84F-3DE9F25CA3B6Q35137169-E5600357-EED1-4165-801F-339FDD11A0B1Q35151927-5EDD9165-C8FB-4D81-BB52-A7C94EFF6AD5Q35693028-E40BCC56-EEAE-41F4-B791-C47A80FB5EE8Q35940666-EC8329B5-FE06-4EC6-9363-764395FC0470Q35991747-DE41498C-6DEF-4B21-8A0C-8791B60BDE15Q36189679-8F41564B-E9B6-4421-8276-6015E32C5EA3Q36709214-5E4050F8-4650-4C7D-A212-ADB85AE11BC6Q36956303-660FC805-352B-4A7D-BB9A-48ED9502A6B9Q37176694-BEEFB89C-54C6-440C-B816-FB8B9D4ED417Q37540412-152F9CAB-DBF7-4A1B-87EC-B050D8F9F8C8Q37683267-D449E957-37BE-4446-AF6D-394FFC528D47Q37695292-DF499FAE-F8E7-4AD4-85E2-B8FA41E31B57Q37826768-A40C3E36-70C8-407D-96BC-0B129652988DQ37880900-B61FC3D2-41CA-4BF3-B242-9C319871AE29Q37929093-5EC99623-5EAB-4485-9038-BFF630088028Q37946405-281BAA77-4E7F-4573-BA94-5EA5B7506FB6Q38066494-5102A724-7592-46E1-A593-ECA669E6CF08Q38162732-08736CF4-F82F-4AB0-8AD7-543C40083C9CQ38162943-6720EFFA-F458-4C77-B344-30E7264F6450Q38206101-FC4F5E0E-8E24-42DC-8A63-3567E6197934Q38255835-3DA3C3A2-19C4-4E68-9D22-780E100D47D7Q38856602-08AC3CFB-9F73-4460-90E4-0934263BADC8Q39164871-B6D4A40A-DEBE-4763-89FC-639DE0797802
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Serotonin and epilepsy.
@ast
Serotonin and epilepsy.
@en
type
label
Serotonin and epilepsy.
@ast
Serotonin and epilepsy.
@en
prefLabel
Serotonin and epilepsy.
@ast
Serotonin and epilepsy.
@en
P2093
P2860
P1476
Serotonin and epilepsy.
@en
P2093
Rita Jakus
Valeria Kecskemeti
P2860
P304
P356
10.1111/J.1471-4159.2006.04277.X
P407
P50
P577
2007-01-24T00:00:00Z